Immunotherapy is a modern approach to cancer treatment that uses a patient’s immune system to help fight tumours. It has made an incredible impact...
Vous n'êtes pas connecté
Laboratorium: Russian scientists are developing a new method for identifying and treating cancers. The therapy aims to deliver medication directly to a patient’s tumour via the bloodstream, minimising damage to healthy tissues. The technology is designed to target tumours specifically, reducing the systemic side effects often associated with traditional cancer treatments like chemotherapy, which can […]
Immunotherapy is a modern approach to cancer treatment that uses a patient’s immune system to help fight tumours. It has made an incredible impact...
A study co-led by UCLA scientists in, the USA, has found targeting a protein called endocan and its related signaling pathway could be a promising new...
Circulating tumour DNA (ctDNA) is fragments of DNA released into the blood by tumours. It’s known to be important for disease prognosis but can be...
Highlights: Lung cancers need elevated copper levels for growth, emphasizing the need to monitor copper in cancer r
A new paper by a team of Concordia researchers from the departments of Biology and Physics proposes a novel method of fighting cancer tumours that...
Scientists have developed a new AI-based method to diagnose breast cancer at very early stages. The approach could save lives but there are hurdles to...
Computer models are advancing precision antibiotic therapy by predicting the most effective treatments, reducing resistance, and optimizing patient...
Discover how light-controlled ink in bioprinted tissues offers a non-invasive method for heart repair, revolutionizing cardiac therapy and tissue...
Like all cancers, bladder cancer develops when abnormal cells start to multiply out of control. But what if we could put a lid on their growth?...
An FDA-approved medication called glucarpidase could serve as an antidote to kidney toxicity in patients receiving the chemotherapy drug methotrexate...